yeah you'd think....but we can't even sign a petition for a Retigabine study.Andrew said:you'd think more would be done about Tinnitus.
Dear Mr. Hansen:
Thank you for your recent e-mail. Although the in vitro research was done in my lab, Dr. <name withheld> is the expert on tinnitus. I have already suggested that we should quantify the neurotoxicity of this compound before we address specific mechanisms. However, we do not have the resources to start new projects. Support for research has been cut substantially.
Dear Jakob, Thank you for your interest in the work. We do not know the mechanism of how retigabine (Trobalt) decreases induced firing of neurons, or whether this activity could suppress symptoms of tinnitus. In light of the known side effects of the drug (blue eyes, skin, tremor, etc) it is not likely to be useful for treating tinnitus, especially long term. Dr. <name withheld>'s lab is currently working on potentially more effective alternatives with fewer or no side effects. However, securing funding for this research remains an uphill battle.
I fully agree with you in your points. But if and when the time comes, we need to move on this full steam ahead.I have no problems signing a petition , I just do not think its time yet . Realize that only one person has had full recovery, I would at least want to see one more person achieving that . Having said that , just the effects that it seems to have on T warrants further study and even a petition but I still think we should gather more data , that cannot hurt and in fact will make such a petition much more likely to achieve something.
Can we not petItion the Global Fund to include Tinnutus as part of its remit? Probably not but at least we can start to think in these terms.
Why dont we get the idea out that this is an emergency medical problem that is growing in numbers globally day by day much as HIV grew.
Wondering if there are any updates.
at least 6 months we will have the autofony reply about the résults of their clinicals trialsI can only speak for myself (and not the group as a whole).
I don't have any further updates at this point; I am still pending a reply from a specific professor in the US. If I do not have a reply by Tuesday (one full week), then I will probably need to go to "plan B". Personally, I do not see a reason as to why there needs to be a MoA for a petition. I would be more comfortable referring to a recent research paper on potassium modulators as a means of demonstrating the theoretical potential of Trobalt as a treatment against tinnitus.
I know another member of the group is pending a response from the ATA.
Number crunching on this board's "trial" participants should be completed, I believe.
Then there is the collection of signatures themselves. A platform needs to be selected for that and then the petition needs to run for a certain period of time to collect the signatures required.
So one way or another, I do not see this petition (and its final deliverable) as happening in "one month". Even if the petition is accepted and the SAB gives it the thumbs up, then it will take time to do the study itself (ie. you will need participants and put them through the treatment which could in itself be eg. 3 months). Don't ask me for specifics, but it would be at least 6 months from now before such a study could be finalized - at least! As I see it, anyway.
at least 6 months we will have the autofony reply about the résults of their clinicals trials
since autofony has the same mechanism function as trobalt
@attheedgeofscience
Sorry to bother you but I forgot to ask, at the beginning of this threat it was mentioned that military should be informed or contacted, has this been done or this is not considered at the moment?
How is one prescribed this?If by"relief" you mean never hearing severe tinnitus (that I heard every second of the day for 5 months when not in the shower- and occasionally even over the shower)- then count me in
My tinnitus reduced significantly within a couple weeks of starting retigabine - to the point of being very tolerable - I would have been thrilled if the improvement would have stopped there-- but it didn't-- I basically can't hear my tinnitus even when searching for it now, occasionally I'll hear it when plugging my ears (but not always when plugging ears)
I have no doubt that retigabine is responsible for my initial volume reduction.butto tell you the truth the continued improvement that I have seen in the past couple months-- I'm not sure if its from retigabine (because I am off of it now) or through brain plasticity being able to file away the insignificant sound that I was left with
We are not planning to threaten anyone...
The petition some members of this board are in the process of preparing, would in the ideal situation end up becoming a study with the aim of demonstrating Trobalt's efficacy in the treatment of tinnitus, and hence potentially move Trobalt from being off- to on-label in the treatment of tinnitus.
Whatever happens with Autifony's clinical trial would have no impact on that. The only purpose of a study such as the above would be to "widen" the availabililty/applicability of Trobalt for other purposes - ie. tinnitus.
From my point-of-view, at least.
you're right we know never if autofony will show good results .we have to achieve our goal to have new version of trobalt without the side effects.
Dear Jakob,
Thank you for your interest in my research. There is one tinnitus update that I would like to share with you: we have developed and tested a novel and more specific Kv7.2/3 (KCNQ2/3) activator that works much better than retigabine both for epilepsy and for tinnitus. This novel Kv7.2/3 activator is more specific than retigabine and is less toxic, but keep in mind that all this work has been performed only in mice and rats. The manuscript describing this work in detail will be submitted for publication within the next month or so and I hope that the new compound will hopefully go to clinical trials soon.
I am not an MD and therefore clinical trials, effects of drugs on tinnitus sufferers, medical advice, and clinical applications of my findings in humans are outside of my expertise/control. I know the exact MOA of retigabine on Kv7 channels (you can read it in my 20xx publication in <name withheld>), but I do not know the MOA of retigabine on tinnitus and therefore I can not answer your question.
Beautifully said - and I hope this answers people's question as to why this is a good idea.It would represent a "quick-win" way of addressing a need of treating tinnitus pharmacologically while other compounds are tested and clinical trials being executed. It would also help establish potential treatment protocols such as treatment duration and dosage regimes - and potentially determine if Trobalt could be curative in some cases (ie. not require continuous suppressive treatment).
Incredible work ATEOS. Thank You.As this board knows, I have been in touch with various top-level professors regarding tinnitus research - professors who at-the-edge-of-science within their field of work. A third researcher has come back with a reply regarding the pharmacological mechanism of action of Trobalt. The reply regarding Trobalt is identical to that of the other two professors: the mechanism of action in relation to tinnitus suppression is not known. However, the researcher did share with me an interesting development...
[Note: To protect the source, I had to edit one sentence which now reads in part: "20xx publication in <name withheld>" in the quote above]
So at this point it is probably safe to say that the mechanism of action is not known (ie. three different researchers have now independently confirmed that). However, it is probably also safe to say that the improvements the +10 trialees on this forum have experienced in terms of tinnitus suppression is not imagined. There really is good reason to suspect that Trobalt works for some cases of tinnitus with a specific cause. A paper titled "Pharmacodynamics of potassium channel openers in cultured neuronal networks", released online March 25th, 2014, helps support this "fact" (theoretically).
As I stated in an earlier post, I do not represent the petition group; I am just a member (who shares information in public).
I do not know what the next step will be. There has been several pieces of information to take in from various sources over the past week - and many, many discussions back-and-forth in our offline PM-system. Perhaps the petition will go ahead, perhaps not. My own position is that a study to move Trobalt from off- to on-label in the treatment of tinnitus should take place "somehow". It would represent a "quick-win" way of addressing a need of treating tinnitus pharmacologically while other compounds are tested and clinical trials being executed. It would also help establish potential treatment protocols such as treatment duration and dosage regimes - and potentially determine if Trobalt could be curative in some cases (ie. not require continuous suppressive treatment). To my knowledge, no one on this board has so far reached a daily dose of 1200mg. What would the effect be if such a dose is maintained for eg. "a week"? The paper above mentions how dosage is potentially quite important if the desired pharmacological effect is to be achieved. There are many (remaining) questions to be answered in my opinion...
Dear Mr. Hansen:
I am in receipt of your comments about Trobalt (Retigabine), as a prelude to a clinical trial for treating tinnitus, to be underwritten by ATA that you are seeking. I appreciate your interest in our work. I am aware also that you have been in contact with <information withheld by ATEOS: statement refers to name(s) of research colleague(s)>. I have been in contact also with the other <information withheld by ATEOS: statement refers to name(s) of research colleague(s)>. Thus, they have asked me to respond in their behalf as pertains to your requests. We would surmise or speculate that the MOA of Trobalt as follows:
"The primary mechanism of action of Trobalt (Retigabine) is Kv channel activation, which hyperpolarizes the membrane and reduces action potential firing. Another possible mechanism is GABA receptor activation, which increases the magnitude of the membrane potential and reduces the triggering of action potentials".
As per us contributing further to the petition, and the comments you included herein:
1) Your expert testimony that doing a study on Trobalt in relation to tinnitus suppression would be worthwhile under certain circumstances such as - example only - treatment duration not exceeding 3 months and in cases of patients with "catastrophic tinnitus".
2) Your expert testimony on the theoretical possibility of Trobalt having a curative potential (as opposed to only a treatment potential requiring continuous medication for suppressive effect).
3) Anything else which could potentially be of value (contacts with <information withheld by ATEOS>).
We feel strongly that we are not in a position nor do we have sufficient experimental data to comment on these three (1, 2, 3) statements.
If there is to be funding of research as pertains to this topic for further data collection as per our research platforms, then we would greatly appreciate consideration of receiving such funding. We are presently operating our labs without sufficient internal or external funding. Quantitative data on Trobalt neurotoxicity is lacking and can be established by our laboratories. A systematic search for and evaluation of compounds with similar effects to Trobalt, but with less toxicity, is perhaps also possible from our labs.